Sino Biopharmaceutical
(SEHK) 1177
Sino Biopharmaceutical Financials at a Glance
Market Cap
HK$89.21B
Revenue (TTM)
CN¥31.83B
Net Income (TTM)
CN¥2.34B
EPS (TTM)
HK$0.14
P/E Ratio
36.11
Dividend
HK$0.09
Beta (Volatility)
0.05 (Low)
Dividend
HK$0.09
Beta (Volatility)
0.05 (Low)
Price
HK$5.02
Volume
19,776,000
Open
HK$4.87
Price
HK$5.02
Volume
19,776,000
Open
HK$4.87
Previous Close
HK$4.99
Daily Range
HK$4.87 - HK$5.17
52-Week Range
HK$4.29 - HK$9.12
Dividend
HK$0.09
Beta (Volatility)
0.05 (Low)
Price
HK$5.02
Volume
19,776,000
Open
HK$4.87
Previous Close
HK$4.99
Daily Range
HK$4.87 - HK$5.17
52-Week Range
HK$4.29 - HK$9.12
1177 News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Sino Biopharmaceutical
Industry
Pharmaceuticals
Sector
Health CareEmployees
21,435
CEO
S Y Tse
Website
www.sinobiopharm.comHeadquarters
Wan Chai, HK
1177 Financials
Key Financial Metrics (TTM)
Gross Margin
82%
Operating Margin
22%
Net Income Margin
7%
Return on Equity
7%
Return on Capital
14%
Return on Assets
3%
Earnings Yield
2.77%
Dividend Yield
1.80%
Payout Ratio
0.00%
Stock Overview
Market Cap
HK$89.21B
Shares Outstanding
17.88B
Volume
19.78M
Avg. Volume
76.81M
Financials (TTM)
Gross Profit
CN¥26.13B
Operating Income
CN¥6.95B
EBITDA
CN¥7.26B
Operating Cash Flow
CN¥9.29B
Capital Expenditure
-CN¥1.70B
Free Cash Flow
CN¥7.59B
Cash & ST Invst.
CN¥22.56B
Total Debt
CN¥16.08B
Sino Biopharmaceutical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
CN¥7.13B
+9.8%
Gross Profit
CN¥5.82B
+10.8%
Gross Margin
81.58%
N/A
Market Cap
HK$89.21B
N/A
Market Cap/Employee
HK$3.66M
N/A
Employees
24,379
N/A
Net Income
-CN¥522.62M
-316.6%
EBITDA
CN¥1.66B
+52.9%
Quarterly Fundamentals
Net Cash
CN¥6.49B
+34.8%
Accounts Receivable
CN¥6.64B
+33.7%
Inventory
CN¥2.26B
-4.9%
Long Term Debt
CN¥7.65B
+267.8%
Short Term Debt
CN¥8.42B
+9.3%
Return on Assets
3.08%
N/A
Return on Invested Capital
13.69%
N/A
Free Cash Flow
CN¥1.44B
+8.2%
Operating Cash Flow
CN¥1.58B
+2.7%